Open Access<p>Efficacy and Safety of Apatinib in Treatment of Unresectable Intrahepatic Cholangiocarcinoma: An Observational Study</p>
Author(s) -
Yubin Hu,
Huilong Lin,
Mingzhi Hao,
Yan Zhou,
Qizhong Chen,
Zhangxian Chen
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
ISSN - 1179-1322
DOI - 10.2147/cmar.s254955
Subject(s) - apatinib , medicine , adverse effect , gastroenterology , response evaluation criteria in solid tumors , intrahepatic cholangiocarcinoma , confidence interval , neutropenia , progressive disease , progression free survival , observational study , oncology , surgery , chemotherapy
Unresectable intrahepatic cholangiocarcinoma (ICC) has a poor prognosis. The aim of this study was to evaluate the efficacy and safety of apatinib for patients with unresectable ICC.